DENKHAUS DONALD A

CIK 00012784392 companiesCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001278439

Recent Transactions

50 trades

Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−5,468→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−30,000→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−20,000→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2026-07-15$31.50/sh−498,773→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−33,500→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−15,000→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−29,524→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−23,248→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−18,115→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−1,414→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−1,894→ 0 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-29+1,334→ 498,773 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-29−1,334→ 178,163 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-08−1,413→ 179,497 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-08+1,413→ 497,439 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-21−947→ 180,910 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21+947→ 496,026 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-20+5,468→ 181,857 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-20+18,115→ 176,389 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14+4,000→ 495,079 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-02-14−4,000→ 158,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-01-08$2.24/sh+50,000→ 491,079 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-01-08−50,000→ 162,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-27−1,333→ 212,274 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27+1,333→ 441,079 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09+1,413→ 439,746 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-09−1,413→ 213,607 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-11-21+2,841→ 215,020 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-21+23,248→ 212,179 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-02-15−4,000→ 188,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-02-15+4,000→ 438,333 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-02-05$4.01/sh+40,000→ 434,333 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-02-05−40,000→ 192,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-27−1,333→ 232,931 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-27+1,333→ 394,333 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-08+29,524→ 230,024 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-08+4,240→ 234,264 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-08-03$1.13/sh+60,000→ 393,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-08-03−60,000→ 200,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-02-15−4,000→ 260,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-02-15+4,000→ 333,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-01-24$0.79/sh+50,000→ 329,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-01-24−50,000→ 264,500 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-27+4,000→ 314,500 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-12-27+15,000→ 310,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2022-12-06+1,334→ 279,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-06−1,334→ 295,500 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2022-11-11$16.59/sh−20,000→ 277,666 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2022-09-14$15.34/sh−20,000→ 297,666 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-02-14+12,000→ 296,834 total

Companies

Recent Filings

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134

View on SEC.gov